Our Team
Armin Rad, PhD
Co-founder and CEO
Leila Daneshmandi, PhD
Co-founder and COO
Bret Schipper, MD, FACS
CMO
John Strahley, MBA
CFO
Joel Levine, MD
Director of Creativity
Junhan Zhao
Director of AI
Jacob Schillo, PhD
Cancer Biology Scientist Level II
Duran Gonzalez, MS
Microfluidics Scientist Level I
Rebekah Peplinski, PhD
Cancer Biology Scientist Level I
James Elia
AI & Bioinformatics Scientist Level I
Thuany Marielle de Carvalho Lachos
Technician
Board of Directors
Mason Reiner, MBA
Ambit Health Ventures
Daniel Wagner, MBA
Connecticut Innovations
Chris Willenken
Blackwood Healthcare Breakthroughs VC
Vivek Ramakrishnan, PhD
Outcome Capital
Clinical Advisory Board
Tiago Biachi
Moffitt Cancer Center
John Birk, MD
UConn Health
Sarah Hoffe, MD
Moffitt Cancer Center
Danny Khalil, MD, PhD
Memorial Sloan Kettering Cancer Center
Alvaro Menendez, MD
Hartford Healthcare
Matthew Strickland, MD
Mass General Hospital/Harvard Medical School
Konstantinos Votanopoulos, MD, PhD, FACS
Advocate Health
David Wozny, DO
Rochester Regional Health
Scientific Advisory Board
Raman Bahal, PhD
UConn School of Pharmacy
Charles Giardina, PhD
UConn Molecular and Cell Biology
Andre Levchenko, PhD
Yale Biomedical Engineering
Mu-Ping Nieh, PhD
UConn Institute of Materials Science
Ali Tamayol, PhD
UConn Biomedical Engineering
Ming Tan, PhD
Wainamics
Gilmer Valdes, PhD
Moffitt Cancer Center AI Department
Business Advisory Board
Alain Berinstain, PhD
AB Strategy
James Fasi, CFP®, CEPA®
UBS Bank
Troy Quast, PhD
Medical Economist
Jennifer Read, GMPro™ QAPro™
Helios Spectrum Consulting
Roger Shedlin, JD
WIN
Eugene Shteyn
Blackwood Healthcare Breakthroughs VC
Daniel Simpson, RAC
DCNDx
Eric Tan, PhD, MBA
Blackwood Healthcare Breakthroughs VC
Gerald F. Vovis, PhD
Vovis Enterprises
Investors
Partners
